CureBay
PrivateLast Round
Early Funding
Oct 22, 2026
Est. Valuation
$75M
Total Funding Raised
$45.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CureBay operates in Healthcare & Life Sciences and is based in Bhubaneswar. Its latest recorded funding round was an Early Funding round in October 2026.
CureBay is a health-tech company that operates a hybrid network of e-clinics and pharmacies to provide accessible and affordable primary healthcare services to rural communities in India.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, E-commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureBay Comparables
Compare CureBay with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| M-SWASTH Solutions Private Limited | 89% | |
| Medyseva | 87% | |
| Gramin Health Care | 84% |
For institutional investors. Book with your work email.
CureBay Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 22, 2026 | ||||
| Series B | May 20, 2025 | ||||
| Series A Extension | Jan 5, 2024 | ||||
| Debt | Aug 26, 2023 | ||||
| Series A | Nov 9, 2022 | ||||
Angel | Sep 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CureBay Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bertelsmann Investments | Early Funding, Series B |
| Alteria Capital | Early Funding |
| InCred Wealth | Angel, Series A Extension |
| Stride Ventures | Debt |
| Elevar Equity | Early Funding, Series B, Series A Extension, Series A |
| Trifecta Capital | Early Funding |
| IvyCap Ventures | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$11M raised, led by IvyCap Ventures.
- Apr 16, 2026
Monthly visitors grew 39% MoM, reaching 45.9K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- invests_into_assetsOct 22, 2026
CureBay Technologies Pvt Ltd plans to allocate resources to establish more local health centers that provide essential medical services and improve rural healthcare access.
- expands_offices_inOct 22, 2026
CureBay Technologies Pvt Ltd expands its presence across India, including into Andhra Pradesh, with fresh capital supporting its delivery network and technology capabilities.
- receives_financingOct 22, 2026
CureBay Technologies Pvt Ltd raises around $10.6M in a pre-Series C round, including $3.16M in debt from Trifecta Capital, Alteria Capital and VentureSoul Partners and over ₹69 Cr in equity led by IvyCap Ventures, to expand geographically, strengthen its delivery network, and invest in AI and technology.
- receives_financingOct 22, 2026
CureBay Technologies Pvt Ltd receives $10.5M in a Pre Series C round in India on Oct 22nd '26, with equity led by IvyCap Ventures and debt from Trifecta Capital, Alteria Capital and VentureSoul Partners to expand its healthcare delivery network and strengthen AI and proprietary technology.
- has_revenueOct 22, 2026
CureBay Technologies Pvt Ltd reports $17.9M in annual recurring revenue for FY26, according to co-founder and CEO Priyadarshi Mohapatra.
For institutional investors. Book with your work email.
CureBay Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CureBay's valuation, stock price, and market status.
Is CureBay a public or private company?
CureBay is a private company.
What is the current stock price of CureBay?
CureBay is a private company, so its shares have no public market price. Caplight tracks CureBay's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CureBay worth (valuation)?
CureBay's valuation is estimated at $75.0M based on funding round data.
Can I buy CureBay stock?
CureBay shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CureBay's last funding round?
CureBay's most recent funding round was Early Funding on October 22, 2026.
Who are the main investors in CureBay?
Key investors in CureBay include Bertelsmann Investments, Stride Ventures, Elevar Equity, IvyCap Ventures.
Will CureBay IPO soon?
No public IPO plans have been announced for CureBay.
How can I track CureBay secondary market activity?
Caplight tracks bids, offers, and trades in CureBay's shares on secondary markets.